RMGP Bio-Pharma Investment Fund, L.P. — Form D
RMGP Bio-Pharma Investment Fund, L.P. of Herzliya, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-10-22. The offering totals $80.0M, of which $2.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-10-22
- Form: D
- Accession: 0001756063-18-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $80.0M
- Amount sold: $2.0M
- Remaining: $78.0M
- Minimum investment: $50K
- Investors: 11
- Date of first sale: 2018-10-15
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-324062
Issuer
- Name: RMGP Bio-Pharma Investment Fund, L.P.
- CIK: 0001756063
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2017
- Address: 11 Ha'manofim Street, Herzliya, L3, 46140
- Phone: 212-792-6961
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Assaf Keret | Director | Herzliya, L3 |
More